1. The rare diagnosis of Von Hippel-Lindau disease in a 29-year-old patient.
- Author
-
Rotsos, Tryfon, Bouzika, Peggy, Sotirianakou, Maria-Evanthia, Symeonidis, Chrysanthos, Giachos, Ioannis, Papakonstantinou, Evangelia, Paraskevopoulos, Theodoros, and Georgalas, Ilias
- Subjects
VON Hippel-Lindau disease ,DIAGNOSIS ,PLATELET-derived growth factor ,ENDOTHELIAL growth factors ,TUMOR suppressor genes ,OPTICAL coherence tomography - Abstract
This article discusses a case of Von Hippel-Lindau (VHL) disease, a rare genetic disorder that causes tumors to develop in multiple organs, including the eyes. The patient in this case had retinal tumors and renal cysts, and was treated with laser photocoagulation to resolve the retinal detachment and improve vision. The article emphasizes the importance of long-term tumor surveillance and genetic counseling for VHL patients and their families. Treatment options for retinal tumors include laser photocoagulation, cryotherapy, photodynamic therapy, and plaque brachytherapy, with the choice depending on individual factors. Genetic analysis can help guide treatment decisions and predict prognosis. Overall, personalized treatment and ongoing monitoring are necessary for managing VHL-related eye tumors. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF